DISEASE INDICATIONS: Multiple Sclerosis

MANUFACTURER: Merck Serono Europe Limited

USAGE: Oral

MEDICINE APPROVED BY:

European Medical Agency (EMA)

Food and Drug Administration (FDA)

Health Canada

Therapeutic Goods Administration (TGA)

Medsafe (NZ)

Mavenclad (cladribine) is an oral prescription medication used for treating relapsing-remitting multiple sclerosis (RRMS) by targeting B and T lymphocytes and reducing the frequency and severity of MS relapses by slowing down the progression of the disease.